+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Polymorphisms of the 2-Adrenergic Receptor Determine Exercise Capacity in Patients With Heart Failure



Polymorphisms of the 2-Adrenergic Receptor Determine Exercise Capacity in Patients With Heart Failure



Circulation Research 86(8): 834-840




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067810369

Download citation: RISBibTeXText

DOI: 10.1161/01.res.86.8.834


Related references

Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circulation Research 86(8): 834-840, 2000

Polymorphisms of the beta-2 adrenergic receptor affect exercise capacity in patients with heart failure. Journal of Investigative Medicine 44(7): 394, 1996

Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. American Heart Journal 144(5): 840-846, 2002

Beta2-adrenergic receptor polymorphisms influence the resting and exercise haemodynamics in the patients with chronic heart failure. European Heart Journal 24(Abstract Supplement): 247, August-September, 2003

Dissociation between exercise hemodynamics and exercise capacity in patients with chronic heart failure and marked increase in ejection fraction after treatment with beta-adrenergic receptor antagonists. American Journal of Cardiology 91(3): 356-360, 2003

The Ile164 beta2-adrenergic receptor polymorphism is associated with decreased exercise capacity in patients with heart failure. Circulation 100(18 SUPPL ): I 247, Nov 2, 1999

Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF). European Journal of Heart Failure 12(8): 874-882, 2011

Effects of long-term beta-adrenergic blockade on exercise capacity in patients with chronic heart failure. Balady, G J, Pina, I L American Heart Association Monograph Series; Exercise and heart failure: 141-170, 1997

Beta-2 adrenergic receptor gene polymorphisms Gln27Glu, Arg16Gly in patients with heart failure. Bmc Cardiovascular Disorders 9: 50, 2010

Genetic polymorphisms of the human beta2 adrenergic receptor predict survival in patients with heart failure. Circulation 96(8 SUPPL ): I92, 10/21/97, 1997

Polymorphisms in the beta1-, beta2- and beta3-adrenergic receptor genes among patients with congestive heart failure. European Heart Journal 20(ABSTR SUPPL ): 629, 1999

Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure. Circulation. Arrhythmia and Electrophysiology 6(1): 137-143, 2013

Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients. British Journal of Clinical Pharmacology 71(4): 556-565, 2011

Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy. American Journal of Medicine 117(7): 451-458, 2004

Exercise mediated changes in lymphocyte beta adrenergic receptor density in patients with heart failure. Circulation 76(4 PART 2): IV-308, 1987